Search results
Yale Medicine on H5N1 Bird Flu: What You Need to Know
Sierra Sun Times· 6 days agoThe CDC says the public health risk is “low,” but there are still some precautions you can take. May...
Seaweed - The Next Trendy Superfood?
Mercola· 5 days agoData from the market research firm Mintel said that kelp seaweed could be the next rising superfood. According to a Food Navigator article,2 the firm’s data, which was acquired through their ...
Reviews Cross-Journal Editorial Team
Nature· 4 days agoReviews Cross-Journal Editorial Team
The 32 greatest Tom Cruise movies
Games Radar· 5 days agoFor decades, the name Tom Cruise has been synonymous with Hollywood movies. Raised in near poverty under an abusive father, Cruise took up acting in high...
Dow Likely To See Further Downside Amid Steep Drop By Salesforce
RTT News· 4 days agoThe major U.S. index futures are currently pointing to a lower open on Thursday, with the Dow futures showing a notable move to the downside. A steep drop by shares of Salesforce (CRM) is likely ...
Study shows N95 masks near-perfect at blocking escape of airborne COVID-19
Medical Xpress· 4 days agoThe study, "Relative efficacy of masks and respirators as source control for viral aerosol shedding from people infected with SARS-CoV-2", was published May 29 in eBioMedicine. Milton is a UMD ...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 2 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 days agoLive from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC PR Newswire SUZHOU, China, and ROCKVILLE, Md., June 1, 2024 SUZHOU, China ...
Strong trial results for Pfizer lung cancer drug
Fox Bangor· 3 days agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung...
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1...
Morningstar· 2 days agoNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO ...
